D-0664-2017 Class II Terminated
FDA drug recall D-0664-2017 was initiated by Medisca, Inc. on Apr 3, 2017 and is designated Class II. Reason for recall: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection The recall status is terminated (terminated Jun 18, 2019).
Recall details
- Product Type
- Drugs
- Report Date
- Apr 19, 2017
- Initiation Date
- Apr 3, 2017
- Termination Date
- Jun 18, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-06), c) 5 grams (NDC 38779-0891-03), d) 25 grams (NDC 38779-0891-04), and e) 100 grams (NDC 38779-0891-09) Bottles, Packed by MEDISCA INC. PLATTSBURGH, NY 12901; Product Code 0891
Reason for recall
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Distribution pattern
Nationwide, Australia, Bahamas, Italy, Singapore, Thailand, United Kingdom
Code information
a) 124880/D,124880/O, 130940/J, 135312/E b) 124880/C 124880/F 124880/I 124880/N 130940/D 130940/I 135312/D 135312/I 136546/D 139489/B c) 124880/B, 124880/H, 124880/M, 130940/C, 130940/H, 135312/C, 135312/H, 136546/C d) 124880/A ,130940/B, 130940/G, 135312/B, 135312/G, 136546/B, 139489/A e) 124880/G, 124880/J, 124880/L,130940/A, 130940/F, 135312/A, 135312/F, 136546/A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0664-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026